199 related articles for article (PubMed ID: 23869777)
1. Recent advances in small molecule prodrugs for cancer therapy.
Wang P; Jin X; Cai J; Chen J; Ji M
Anticancer Agents Med Chem; 2014 Mar; 14(3):418-39. PubMed ID: 23869777
[TBL] [Abstract][Full Text] [Related]
2. Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics.
Sharma C; Seo YH
Molecules; 2018 Oct; 23(11):. PubMed ID: 30356024
[TBL] [Abstract][Full Text] [Related]
3. The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy.
Legigan T; Clarhaut J; Tranoy-Opalinski I; Monvoisin A; Renoux B; Thomas M; Le Pape A; Lerondel S; Papot S
Angew Chem Int Ed Engl; 2012 Nov; 51(46):11606-10. PubMed ID: 22996951
[TBL] [Abstract][Full Text] [Related]
4. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT.
Tietze LF; Schmuck K
Curr Pharm Des; 2011; 17(32):3527-47. PubMed ID: 22074425
[TBL] [Abstract][Full Text] [Related]
5. Strategies on the development of small molecule anticancer drugs for targeted therapy.
Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
[TBL] [Abstract][Full Text] [Related]
6. Prodrugs in photodynamic anticancer therapy.
Musiol R; Serda M; Polanski J
Curr Pharm Des; 2011; 17(32):3548-59. PubMed ID: 22074426
[TBL] [Abstract][Full Text] [Related]
7. Development of prodrugs for enzyme-mediated, tumor-selective therapy.
Yoon KJ; Potter PM; Danks MK
Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):107-13. PubMed ID: 15777218
[TBL] [Abstract][Full Text] [Related]
8. Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment.
Maslah H; Skarbek C; Pethe S; Labruère R
Eur J Med Chem; 2020 Dec; 207():112670. PubMed ID: 32858470
[TBL] [Abstract][Full Text] [Related]
9. Macromolecular Prodrugs Containing Organoiron-Based Compounds in Cancer Research: A Review.
Mukaya EH; Mbianda XY
Mini Rev Med Chem; 2020; 20(9):726-738. PubMed ID: 31702511
[TBL] [Abstract][Full Text] [Related]
10. Interfering with Metabolic Profile of Triple-Negative Breast Cancers Using Rationally Designed Metformin Prodrugs.
Babak MV; Chong KR; Rapta P; Zannikou M; Tang HM; Reichert L; Chang MR; Kushnarev V; Heffeter P; Meier-Menches SM; Lim ZC; Yap JY; Casini A; Balyasnikova IV; Ang WH
Angew Chem Int Ed Engl; 2021 Jun; 60(24):13405-13413. PubMed ID: 33755286
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin receptor-mediated specific delivery of paclitaxel prodrugs for efficient cancer therapy.
Huo M; Zhu Q; Wu Q; Yin T; Wang L; Yin L; Zhou J
J Pharm Sci; 2015 Jun; 104(6):2018-2028. PubMed ID: 25820241
[TBL] [Abstract][Full Text] [Related]
12. Natural products and their analogues as efficient anticancer drugs.
Coseri S
Mini Rev Med Chem; 2009 May; 9(5):560-71. PubMed ID: 19456286
[TBL] [Abstract][Full Text] [Related]
13. Recent Trends in
Sun IC; Yoon HY; Lim DK; Kim K
Bioconjug Chem; 2020 Apr; 31(4):1012-1024. PubMed ID: 32163277
[TBL] [Abstract][Full Text] [Related]
14. Prodrug applications for targeted cancer therapy.
Giang I; Boland EL; Poon GM
AAPS J; 2014 Sep; 16(5):899-913. PubMed ID: 25004822
[TBL] [Abstract][Full Text] [Related]
15. Anticancer platinum (IV) prodrugs with novel modes of activity.
Chin CF; Wong DY; Jothibasu R; Ang WH
Curr Top Med Chem; 2011; 11(21):2602-12. PubMed ID: 22039869
[TBL] [Abstract][Full Text] [Related]
16. Metabolism-based anticancer drug design.
Kwon CH
Arch Pharm Res; 1999 Dec; 22(6):533-41. PubMed ID: 10615856
[TBL] [Abstract][Full Text] [Related]
17. Recent Progress of Marine Polypeptides as Anticancer Agents.
Zheng L; Xu Y; Lin X; Yuan Z; Liu M; Cao S; Zhang F; Linhardt RJ
Recent Pat Anticancer Drug Discov; 2018; 13(4):445-454. PubMed ID: 29708076
[TBL] [Abstract][Full Text] [Related]
18. Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs.
Oliveri V; Giuffrida ML; Vecchio G; Aiello C; Viale M
Dalton Trans; 2012 Apr; 41(15):4530-5. PubMed ID: 22354329
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly drug conjugates for anticancer treatment.
Fumagalli G; Marucci C; Christodoulou MS; Stella B; Dosio F; Passarella D
Drug Discov Today; 2016 Aug; 21(8):1321-9. PubMed ID: 27329268
[TBL] [Abstract][Full Text] [Related]
20. Block copolymer prodrugs: Synthesis, self-assembly, and applications for cancer therapy.
Dutta D; Ke W; Xi L; Yin W; Zhou M; Ge Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1585. PubMed ID: 31452353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
